Little information is available on long-term neurodevelopment of premature neonates with invasive candidal infections. We retrospectively studied the outcomes for 25 premature neonates (birth weight, õ1,250 g) with candidemia or candidal meningitis (cases) and compared them with 25 neonates matched for birth weight ({100 g) and gestational age ({1 week) (controls). Durations of antibiotic therapy, artificial ventilation, invasive catheterizations, and hyperalimentation were longer for cases than for controls. Cases had a higher final grade of intraventricular hemorrhage than did controls (median: 3.0 vs. 2.5, respectively; P õ .05). Forty-four percent (11 of 25) of cases and 16% (4 of 25) of controls died (P ú .05), and 29% (4 of 14) of surviving cases and 14% (3 of 21) of controls were disabled (P ú .05). More cases had combined mortality and neurodevelopmental disabilities than did controls (60% vs. 28%, respectively; P õ .05). Use of invasive therapies should be minimized for premature neonates at risk for invasive candidal infection that is associated with adverse outcomes.
Candida species are important pathogens causing serious inMethods fectious complications in the neonatal intensive care unit (NICU).
We identified all neonates admitted to the two, level III Previous studies have demonstrated an increased risk of invasive NICUs at the University of Alberta Hospital and the Royal candidal infection in very low-birth-weight neonates [1] [2] [3] . In a Alexandra Hospital (Edmonton, Alberta, Canada) between Jan-5-year review of candidemia in a large pediatric hospital, 25% uary 1990 and May 1995 who had candidemia or candidal of the patients were premature infants [2] . Antibiotic use, artificial meningitis (cases). Candidemia was identified by at least one ventilation, hyperalimentation, and lipid infusion have been found blood culture positive for Candida species by reviewing the to be predisposing factors in retrospective reviews of the clinical microbiological data from the laboratories. Candidal meningitis characteristics of infected infants [2] [3] [4] .
was defined as the isolation of Candida species from CSF or Previous studies have described mortality rates among and as ú45 1 10 6 WBCs/L in the CSF and the presence of candideinfectious or therapeutic complications in premature neonates mia [9] . Patients with a discharge diagnosis of candidal meninwith invasive candidal infections [3, 5 -7] . Mortality rates gitis were identified by reviewing the health records. Premature ranged from 25% to 60% among low birth weight premature neonates with birth weights of õ1,250 g (controls) were inneonates. Little information has been reported on the neurodecluded in the comparative study of mortality and neurodevelopvelopmental outcome for this population. In a case-control mental outcomes. Neonates with major congenital anomalies study of 10 premature infants (birth weight, õ1,500 g), Baley were excluded from the analysis. et al. [8] reported that the 2-year outcome for infants surviving Controls were matched for birth weight ({100 g) and gestasystemic candidiasis was comparable with that for matched tional age ({1 week). Where possible, controls were matched controls and that other complications of prematurity may confor inborn and outborn status (deliveries outside the tertiary tribute to poor outcome. We thus conducted a retrospective hospital that required transport to the NICU for further care). case-control study of mortality in and neurodevelopmental out-
The admission dates of the control were matched within 3 comes for premature neonates (birth weight, õ1,250 g) for months where possible. whom Candida was isolated from the blood or CSF. The risk Because blood cultures were not done daily, the duration of factors for candidemia and candidal meningitis were also evalucandidemia could not be established definitely. The maximum ated. In addition, the relationship between antifungal therapy duration of candidemia was defined as the period from the first and the outcome of invasive candidal infection was studied.
positive blood culture to the first negative blood culture. The minimum duration was defined as the period from the first positive blood culture to the last positive blood culture. Evi-therapy, corticosteroid treatment, aminophylline use, hyperalidelay (MDI, ú3 SDs below the mean). Growth retardation was defined as weight, height, or head circumference ú2 SDs below mentation, and lipid infusion were documented. The day of infection was defined as the first day of a positive blood the mean. Statistical analysis. Results are expressed in means { SD. and/or CSF culture. All of the above-mentioned factors before the day of infection were analyzed for the cases. An equivalent Data on subjects were compared between the two groups by using correlated t, Wilcoxon signed-rank, and Fisher's exact period for the controls was used for the analysis of these factors. The presence of arterial and central venous catheters at the tests for continuous parametric, continuous nonparametric, and noncontinuous variables, respectively. The relationship betime of candidemia and the number of days before the removal of those catheters after the first positive blood culture were tween the total dose of antifungal drugs and outcome (mortality, MDI, or PDI) was examined by Student's t and Pearson's also documented. The incidence of patent ductus arteriosus and that of necrotizing enterocolitis were recorded for both cases product moment tests as appropriate. The relationship between the initial and final grades of IVH and candidal infection was and controls.
The total dose of antifungal therapy was documented. Amanalyzed by two-way analysis of variance (ANOVA). A P value of õ.05 was considered significant. photericin B can affect serum creatinine and potassium levels, and 5-fluorocytosine can cause bone marrow suppression. Change in the serum creatinine level, the highest serum creatiResults nine level, and the lowest serum potassium level during amphotericin B therapy were documented. Any leukopenia (absolute Demographics. Twenty-nine neonates admitted to the two NICUs had candidemia or candidal meningitis; of those neoneutrophil count, õ1,000/mm 3 ) in neonates who received 5-fluorocytosine therapy was also recorded.
nates, 25 (86%) met the study criteria. Three neonates were excluded from the study because of the presence of major Intraventricular hemorrhage (IVH) was classified into grades 1, 2, 3, and 4 (parenchymal) [10] according to the highest congenital anomalies. Two neonates had gastroschisis, and one had myelomeningocele; these patients were born at 34 to 37 grade revealed by cranial ultrasonography before and after the candidal infection for the cases. The highest grade of IVH for weeks of gestation with birth weights of 2,220 g to 3,380 g. The fourth neonate who was excluded was born at 35 weeks the controls was recorded for an equivalent period as described above for the analysis of risk factors.
of gestation (birth weight, 3,130 g), and cultures of blood were positive for group B Streptococcus and Candida on days 1 and Multidisciplinary assessments were performed for all the survivors at the Glenrose Rehabilitation Hospital Neonatal and 3 of age, respectively. The frequency of invasive candidal infection in the premaInfant Follow-up Clinic (Edmonton) as previously described [11] . Standardized developmental indices were obtained by ture neonates (birth weight, õ1,250 g) was 3.5% (25 of 713) during the study period. The average birth weights { SDs of qualified psychologists or psychometricians. The mental developmental index (MDI) and the performance developmental inthe cases and controls were 763 { 157 g and 807 { 176 g, respectively. Twenty-one (84%) of the 25 controls were born dex (PDI) of the Bayley Scales of Infant Development [12] were assessed for children younger than 24 months old by and admitted within 90 days of the cases. The other controls were born and admitted within a median of 110 days (mean adjusted age. The Stanford-Binet Intelligence Scale [13] and the Peabody Developmental Motor Scales [14] were used to { SD, 137 { 49 days). Twenty pairs (80%) were matched for gender. Only two pairs were not matched for inborn and outsupplement the MDI and PDI, respectively, for older children performing above the ceiling of the Bayley Scales of Infant born status. Data on candidal infection. The data on blood cultures, Development. Scores recorded as ú3 SDs below the mean were assigned as 49.
CSF cultures, and CSF cell counts for the 25 cases are shown in table 1. Seventy-seven percent (20 of 26) of the isolates The neurological and developmental examinations were completed by two pediatricians with experience in neonatal were Candida albicans. There were four isolates of Candida parapsilosis and two isolates of Candida glabrata. Both follow-up. Independent confirmatory diagnoses for the physically disabled children were obtained from a pediatric physiat-C. albicans and C. glabrata were isolated from the blood of one case. The mean age { SD at which candidemia or candidal rist. Hearing was assessed by certified audiologists with experience in testing young children. Growth measurements were meningitis was diagnosed was 22 { 15 days (median, 18 days).
The median maximum and minimum durations of candidemia performed with use of standard techniques and procedures by a reliability-tested nurse and an attending pediatrician [15] . The in the cases were 8 and 4 days, respectively. Nineteen of the cases had either an arterial catheter or a measurements were compared with standard growth curves.
Neurodevelopmental disabilities (NDDs) were diagnosed central venous catheter at the time of candidemia. Five cases had arterial catheters only, and two had central venous catheters when one or more of the following were present: cerebral palsy of all types or severity [16, 17] , legal blindness (corrected only. The mean numbers { SDs of days before the removal of arterial and central venous catheters after the first positive visual acuity of the better eye, õ20/200), hearing loss (neurosensory hearing loss in the better ear, ú30 dB), and/or cognitive blood culture, excluding cases 1, 2, and 3 who died within 48 hours of candidemia, were 11 { 6 days and 7 { 6 days, tion at autopsy. Ten cases underwent echocardiography, and an ophthalmology consultation was done during the candidal respectively.
Four of the 25 cases did not undergo a spinal tap during the infection in eight cases. There were no documented cases of endocarditis or endophthalmitis. candidal infection. Eight of the other 21 cases had meningitis. The CSF WBC count for these cases ranged from 1 1 10 6 /L Risk factors. During the preinfection period, there was no difference between cases and controls in regard to frequency to 529 1 10 6 /L. Two cases (no. 16 and 17) had candidal meningitis in the absence of positive blood cultures and had normal of bacterial infections, duration of placement of umbilical arterial and venous catheters, corticosteroid treatment, and amino-CSF WBC counts of 1 1 10 6 /L and 4 1 10 6 /L, respectively. Three cases (no. 6, 13, and 25) had abnormal CSF WBC counts, phylline use (table 2) . Durations of antibiotic therapy, artificial ventilation, placement of peripheral arterial and central venous and cultures of CSF from these cases were negative. CSF from only one of these cases was obtained after amphotericin B catheters, hyperalimentation, and lipid infusion prior to the development of candidal infection were longer for cases than therapy was started.
Fourteen cases underwent renal ultrasonography at least once for controls (P õ .05, correlated t test) (table 2). The mean total duration { SD for placement of peripheral arterial catheduring the candidal infection. Only one of these 14 cases had documented renal involvement. For this case (no. 7), the renal ters during the NICU hospitalization was longer for cases than for controls (14 { 15 vs. 7 { 9 days, respectively; P õ .05, ultrasonogram on day 4 of the candidal infection showed bilateral renal enlargement and loss of cortical medullary differenticorrelated t test). Treatment and complications. Two cases (no. 1 and 2) died ation that was subsequently confirmed to be acute parenchymal disease. This neonate later died of multiple complications of within 24 hours of positive blood cultures and did not receive any antifungal treatment. Four other cases (no. 3, 5, 6, and 10) preterm delivery with no evidence of ongoing candidal infec- cases was not significantly different from the dose received by the cases who died (18.4 { 10.1 vs. 28.2 { 8.1 mg/kg, respectively). All 35 surviving children were assessed at the Neonatal and died during the treatment period and would not have received a complete course of therapy. One case (no. 25) received part Infant Follow-up Clinic. About one-half of the cases (seven of 14) and controls (11 of 21) had growth retardation. Eleven (six of the treatment as liposomal amphotericin B (table 1) . Excluding these seven cases, the average total dose { SD of amphotercases and five controls) of the 35 children (adjusted age at 37-70 months) were assessed with the Stanford-Binet Intelligence icin B received by 18 cases was 21.1 { 10.4 mg/kg. The average total dose { SD of 5-fluorocytosine received was 2,154
Scale and the Peabody Developmental Motor Scales. The average adjusted age { SD for neurodevelopmental assessment was 31 { 1,799 mg/kg.
There was evidence of transient hypokalemia (potassium level, { 19 months for the cases and 28 { 20 months for the controls (P ú .05). Although the MDI for the surviving cases was not õ3.5 mmol/L) in 87% (20 of 23) of the cases during treatment with amphotericin B. The average peak serum creatinine level significantly different from that for the controls (83 { 20 vs. 90 { 20, respectively; b Å .95), the PDI was lower for the cases { SD for all cases during amphotericin B treatment was 101 { 51 mmol/L. Only cases 5, 7, 9, 16, and 19 had a rise in the serum than for the controls (71 { 21 vs. 87 { 18, respectively; P õ .05). There was no correlation between the total dose of creatinine level during the course of amphotericin B treatment. The serum creatinine level in cases 9, 16, and 19 returned to amphotericin B received and the MDI and PDI. Twenty-nine percent (four of 14) of the cases and 14% (three baseline without a decrease in the amphotericin B dose. Case 5 died on day 3 of treatment, and his serum creatinine level rose of 21) of the controls had NDDs (P ú .05; b Å .8). All the children with NDDs had cerebral palsy with or without visual from 65 to 93 mmol/L when the dosage of amphotericin B was increased from 0.2 to 0.8 mg/(kgrd). The amphotericin B dosage or hearing deficit. The average total dose { SD of amphotericin B received by the disabled cases was not significantly different for case 7 was decreased from 1.5 to 1.0 mg/(kgrd) when the serum creatinine level was high (112 mmol/L), and he was the from the dose received by the normal cases (13.4 { 10.3 vs. 20.7 { 9.7 mg/kg, respectively). only case for whom ultrasound examination documented renal disease. Leukopenia was not found in any cases treated with 5-More cases had combined mortality and NDD than did controls (60% vs. 28%, respectively; P õ .05, x 2 test). The odds fluorocytosine.
Blood cultures were repeated for all the cases who received ratio of combined mortality and NDDs for the cases with candidemia or candidal meningitis was 3.9 (95% CI, 1.2 -12.6). a full course of treatment, and there was no evidence of recur- Discussion sepsis and three others had clinical or laboratory evidence of infection. Contrary to some previous studies that found eye The frequency of invasive candidal infection in the premainvolvement in 12.5% to 50% of the neonates [4, 19] , none ture neonates weighing õ1,250 g at birth in our NICU (3.5%) of our cases had endophthalmitis. There was no endocarditis. was comparable with that in other studies [1, 18] . Most neoHowever, these complications were not looked for in every case. nates (86%) with invasive candidal infections had birth weights
In a recent review, Candida was found to be a major cause of õ1,250 g, which has been reported previously [1, 3] .
of urinary tract infection in the NICU [20] ; renal fungus balls Most of the Candida isolates in this study were C. albicans.
were present in 35% of the infected infants. In our study, a Our small study size precludes investigating the relationship beurine culture or a renal ultrasound examination was not done tween outcomes and different Candida species. One positive for every case, but only one of the 25 cases had documented blood culture was found only for six cases. It is unlikely that the renal involvement. We also cannot conclude if candidal meninisolates were contaminants as three of these six cases died of gitis affects the outcome because of the small incidence of meningitis. Moreover, cases 16 and 17 for whom CSF cultures were positive in the absence of candidemia had normal CSF There are no objective data in the literature to suggest the dose Central venous 8 { 9 (5) 7 { 6 (6) of amphotericin B required for the cure of invasive candidal infection [21] . The question remains as to the optimal total dose In conclusion, invasive candidal infections were associated with a higher frequency of mortality and NDDs in premature required for cure. There were three survivors in our study whose total dose of amphotericin B was õ10 mg/kg (cases 13, 14, and neonates with birth weights of õ1,250 g. Other factors, such as prolonged artificial ventilation, may have also contributed 18). The duration of therapy required is likely dependent on the site of infection, which is difficult to ascertain in some neonates.
to adverse outcomes. It is important that the use of invasive therapies such as central venous catheters be minimized for For example, candidemia due to catheter sepsis without organ invasion may require less amphotericin B with removal of the neonates. Further studies are required to define the optimal treatment of candidal infections and to study if systemic candicatheter [22] . Little data have been reported on other forms of therapy (e.g., use of liposomal amphotericin B for very low birth diasis has causative effects on adverse outcomes. weight neonates). A recent study comparing fluconazole with amphotericin B was limited by the small number of patients and the lack of outcome definition [23] .
